Home | Volume 9

Adenoviral (Ad) vectors are widely used in gene therapies, recombinant viral vaccines, and basic science studies. The vectors can deliver therapeutic genes into cells to recover the lost function of some genes, to enhance the ability of host immune systems, or to increase the sensitivity of cancer cells to chemotherapeutic drugs. Several adenoviral vector systems have been developed: first-generation vectors are those with deletion of the E1a and E1b genes, second-generation vectors with deletions of the E1 and another viral gene, and gutless vectors removed all coding sequences for viral proteins. The first- and second-generation vectors are relatively easy to construct and produce. The gutless Ad vectors are substantially superior to any other adenoviral systems for achieving high-level and long- term expression in vivo. The recent developed oncolytic adenoviruses can selectively replicate in cancer cells but not in normal cells, allowing the spread of the viruses throughout the tumors. This review focuses on the advantages and limitations of adenovirus vectors and discusses potential strategies for further improvement of vectors for gene therapy.

Dr. H. Sam Zhou et. al.

Download as PDF : 30._Wang_et_al,_291-300.pdf : 229754 bytes


Previous Article: Adenoviral-mediated overexpression of p16, p53 or TGFβ1 induces apoptosis of BPH cells
Next Article: Designing smart nano-apatite composites: the emerging era of non-viral gene delivery
The Publication:
Adenoviral (Ad) vectors are widely used in gene therapies, recombinant viral vaccines, and basic science studies. The vectors can deliver therapeutic genes into cells to recover the lost function of some genes, to enhance the ability of host immune systems, or to increase the sensitivity of cancer cells to chemotherapeutic drugs. Several adenoviral vector systems have been developed: first-generation vectors are those with deletion of the E1a and E1b genes, second-generation vectors with deletions of the E1 and another viral gene, and gutless vectors removed all coding sequences for viral proteins. The first- and second-generation vectors are relatively easy to construct and produce. The gutless Ad vectors are substantially superior to any other adenoviral systems for achieving high-level and long- term expression in vivo. The recent developed oncolytic adenoviruses can selectively replicate in cancer cells but not in normal cells, allowing the spread of the viruses throughout the tumors. This review focuses on the advantages and limitations of adenovirus vectors and discusses potential strategies for further improvement of vectors for gene therapy.
is not formatted in HTML just yet, but will be available very soon!
Please view as a PDF: 30._Wang_et_al,_291-300.pdf in the meantime.